UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) September 13, 1999
GLOBAL MED TECHNOLOGIES, INC.
----------------------------------------------------
(Exact name of registrant as specified in its charter)
Colorado 0-22083 84-1116894
---------------------------------------------------------------------
(State or other jurisdiction (Commission File No.) (I.R.S. Employer
of incorporation) Identification No.)
12600 West Colfax, Suite C-420, Lakewood, CO 80215
------------------------------------------------------
(Address of principal executive offices) (Zip Code)
(303) 238-2000
--------------------------------------------------
(Registrant's telephone number, including area code)
1
Item 4. Changes In Registrant's Independent Accountants
On September 3, 1999, in its Current Report on Form 8-K, the Company reported
that KPMG LLP was dismissed as the independent accountants for Global Med
Technologies, Inc. (the "Company").
The decision to change accountants was approved by the Company's Board of
Directors.
On September 13, 1999, the Company engaged the accounting firm of Deloitte &
Touche LLP as the Company's independent accountants for the year ending December
31, 1999. Deloitte & Touche LLP are independent accountants for Heng Fung
Holdings Company Limited, the Company's majority shareholder and for eVision
USA.Com, Inc., holder of warrants to purchase 10,000,000 shares of common stock
of Global for $0.25 per share.
During the Company's two most recent fiscal years and subsequent interim period
up to the date of the engagement of Deloitte & Touche LLP, the Company did not
consult with Deloitte & Touche LLP with regard to any matter concerning the
application of accounting principles to any specific transactions, either
completed or proposed, or the type of audit opinion that might be rendered with
respect to the Company's financial statements.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: September 13, 1999 Global Med Technologies, Inc.
By: /s/ Michael I. Ruxin
--------------------------------
Michael I. Ruxin,
Chief Executive Officer
2